BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 16480976)

  • 1. Class III effects of dofetilide and arrhythmias are modulated by [K+]o in an in vitro model of simulated-ischemia and reperfusion in guinea-pig ventricular myocardium.
    Ducroq J; Rouet R; Sallé L; Puddu PE; Repessé Y; Ghadanfar M; Ducouret P; Gérard JL
    Eur J Pharmacol; 2006 Feb; 532(3):279-89. PubMed ID: 16480976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophysiological effects of azimilide in an in vitro model of simulated-ischemia and reperfusion in guinea-pig ventricular myocardium.
    Ducroq J; Rouet R; Puddu PE; Sallé L; Tabourel C; Ducouret P; Gérard JL
    Eur J Pharmacol; 2005 Aug; 518(2-3):165-74. PubMed ID: 16083874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiological effects of dofetilide in an in vitro model of "border zone" between normal and ischemic/reperfused myocardium.
    Rouet R; Picard S; Libersa C; Ghadanfar M; Alabaster C; Gérard JL
    Circulation; 2000 Jan 4-11; 101(1):86-93. PubMed ID: 10618309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. I(Ks) blockade in border zone arrhythmias from guinea-pig ventricular myocardium submitted to simulated ischemia and reperfusion.
    Puddu PE; Sallé L; Gérard JL; Rouet R; Ducroq J
    Fundam Clin Pharmacol; 2012 Aug; 26(4):445-53. PubMed ID: 21781157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dofetilide promotes repolarization abnormalities in perfused Guinea-pig heart.
    Osadchii OE
    Cardiovasc Drugs Ther; 2012 Dec; 26(6):489-500. PubMed ID: 22918600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of altered extracellular potassium and pacing cycle length on the class III antiarrhythmic actions of dofetilide (UK-68,798) in guinea-pig papillary muscle.
    Yang T; Tande PM; Lathrop DA; Refsum H
    Cardiovasc Drugs Ther; 1992 Aug; 6(4):429-36. PubMed ID: 1520650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Saralasin suppresses arrhythmias in an isolated guinea pig ventricular free wall model of simulated ischemia and reperfusion.
    Thomas GP; Howlett SE; Ferrier GR
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1379-86. PubMed ID: 7562511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electromechanical action of dofetilide and D-sotalol during simulated metabolic acidosis in isolated guinea pig ventricular muscle.
    Yang T; Tande PM; Refsum H
    J Cardiovasc Pharmacol; 1992 Dec; 20(6):889-94. PubMed ID: 1282590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiarrhythmic effect of the Ca
    Kirchhoff JE; Diness JG; Abildgaard L; Sheykhzade M; Grunnet M; Jespersen T
    Pflugers Arch; 2016 Nov; 468(11-12):1853-1863. PubMed ID: 27722784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential rate and potassium-dependent effects of the class III agents d-sotalol and dofetilide on guinea pig papillary muscle.
    Marschang H; Beyer T; Karolyi L; Kübler W; Brachmann J
    Cardiovasc Drugs Ther; 1998 Dec; 12(6):573-83. PubMed ID: 10410827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of high extracellular potassium on IKr inhibition by anti-arrhythmic agents.
    Lin C; Ke X; Cvetanovic I; Ranade V; Somberg J
    Cardiology; 2007; 108(1):18-27. PubMed ID: 16960444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The electrophysiological effects of racemic ketamine and etomidate in an in vitro model of "border zone" between normal and ischemic/reperfused guinea pig myocardium.
    Hanouz JL; Repesse Y; Zhu L; Lemoine S; Rouet R; Sallé L; Plaud B; Gérard JL
    Anesth Analg; 2008 Feb; 106(2):365-70, table of contents. PubMed ID: 18227286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of the sodium calcium exchange inhibitor, KB-R7943, on ischemia and reperfusion injury in isolated guinea pig ventricular myocytes.
    MacDonald AC; Howlett SE
    Eur J Pharmacol; 2008 Feb; 580(1-2):214-23. PubMed ID: 18036586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rate-dependent prolongation of cardiac action potentials by a methanesulfonanilide class III antiarrhythmic agent. Specific block of rapidly activating delayed rectifier K+ current by dofetilide.
    Jurkiewicz NK; Sanguinetti MC
    Circ Res; 1993 Jan; 72(1):75-83. PubMed ID: 8417848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Class III antiarrhythmic action by potassium channel blockade: dofetilide attenuates hypoxia induced electromechanical changes.
    Yang T; Tande PM; Lathrop DA; Refsum H
    Cardiovasc Res; 1992 Nov; 26(11):1109-15. PubMed ID: 1291089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levosimendan: effects of a calcium sensitizer on function and arrhythmias and cyclic nucleotide levels during ischemia/reperfusion in the Langendorff-perfused guinea pig heart.
    Du Toit EF; Muller CA; McCarthy J; Opie LH
    J Pharmacol Exp Ther; 1999 Aug; 290(2):505-14. PubMed ID: 10411556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arrhythmia and delayed recovery of cardiac action potential during reperfusion after ischemia. Role of oxygen radical-induced no-reflow phenomenon.
    Aiello EA; Jabr RI; Cole WC
    Circ Res; 1995 Jul; 77(1):153-62. PubMed ID: 7788873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proarrhythmic effects of DL- and D-sotalol on the "border zone" between normal and ischemic regions of isolated ventricular myocardium and antiarrhythmic effects on reperfusion.
    Picard S; Rouet R; Monti F; Puddu PE; Ducouret P; Flais F; Libersa C; Gérard JL
    J Cardiovasc Pharmacol; 1998 Jan; 31(1):126-39. PubMed ID: 9456287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dofetilide, a novel class III antiarrhythmic agent.
    Rasmussen HS; Allen MJ; Blackburn KJ; Butrous GS; Dalrymple HW
    J Cardiovasc Pharmacol; 1992; 20 Suppl 2():S96-105. PubMed ID: 1279316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential class III antiarrhythmic effects of ambasilide and dofetilide at different extracellular potassium and pacing frequencies.
    Gjini V; Korth M; Schreieck J; Weyerbrock S; Schömig A; Schmitt C
    J Cardiovasc Pharmacol; 1996 Aug; 28(2):314-20. PubMed ID: 8856489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.